EYPT - EyePoint Pharmaceuticals EPS misses by $0.18 misses on revenue November, 03 2021 07:10 AM EyePoint Pharmaceuticals Inc. EyePoint Pharmaceuticals (NASDAQ:EYPT): Q3 GAAP EPS of -$0.58 misses by $0.18. Revenue of $9.06M (-42.3% Y/Y) misses by $0.82M. Press Release For further details see: EyePoint Pharmaceuticals EPS misses by $0.18, misses on revenue